Scientific Reports · 2017 · 32 citations · 36 references
Life SciencesGeneticsMolecular BiologyGenome EditingGenomicsMolecular VirologyAntiretroviral TherapyAntiviral TherapyCrispr-cas SystemsGuide Rna DesignRna EditingTherapeutic Genome EditingCrispr Guide Rna DesignCrispr-cas Genome EditingCrispr-cas Target CleavageCrispr-cas9 Genome EditingViral Genetic Variation
Clustered regularly interspaced short palindromic repeats (CRISPR) CRISPR-associated protein 9 (Cas9), including specific guide RNAs (gRNAs), can excise integrated human immunodeficiency virus type 1 (HIV-1) provirus from host chromosomes. To date, anti-HIV-1 gRNAs have been designed to account for off-target activity, however, they seldom account for genetic variation in the HIV-1 genome within and between patients, which will be crucial for therapeutic application of this technology. This analysis tests the ability of published anti-HIV-1 gRNAs to cleave publicly available patient-derived HIV-1 sequences to inform gRNA design and provides basic computational tools to researchers in the field.
36
DNA targeting specificity of RNA-guided Cas9 nucleases
Patrick D. Hsu, David A. Scott, Joshua A. Weinstein et al. · Nature Biotechnology · 2013 · 4.9K citations · Full text
Genome-wide binding of the CRISPR endonuclease Cas9 in mammalian cells.
Xuebing Wu, David Scott, Andrea J. Kriz et al. · PubMed · 2014 · 989 citations
Harnessing the CRISPR/Cas9 system to disrupt latent HIV-1 provirus
Hirotaka Ebina, Naoko Misawa, Yuka Kanemura et al. · Scientific Reports · 2013 · 565 citations · Full text